Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 28-May-15 6:39 PM View:  | Tan Heow Chief Quality&Tech Operations | Pharmacyclics Inc. (PCYC) | 26-May-15 | Disposition (change in control) | 11,721 | $261.25 | $3,062,110.00 | (100%) 11.72K to 0 | |
| 28-May-15 6:33 PM View: | Zanganeh Maky Chief Operating Officer | Pharmacyclics Inc. (PCYC) | 26-May-15 | Disposition (change in control) | 76,988 | $261.25 | $20,113,100.00 | (100%) 76.99K to 0 | |
| 28-May-15 6:33 PM View: | Zanganeh Maky Chief Operating Officer | Pharmacyclics Inc. (PCYC) | 26-May-15 | Disposition | 15,000 | $261.25 | $3,918,750.00 | (3%) 443.28K to 428.28K | |
| 28-May-15 6:30 PM View: | Duggan Robert W Chairman and CEO Director 10% Owner | Pharmacyclics Inc. (PCYC) | 26-May-15 | Disposition (change in control) | 365,755 | $261.25 | $95,553,504.00 | (3%) 13.59M to 13.23M | |
| 28-May-15 6:37 PM View: | Tomasello Shawn Chief Commercial Officer | Pharmacyclics Inc. (PCYC) | 26-May-15 | Disposition (change in control) | 7,302 | $261.25 | $1,907,650.00 | (97%) 7.5K to 0.2K | |
| 28-May-15 6:57 PM View: | van Den Broek Richard Director | Pharmacyclics Inc. (PCYC) | 26-May-15 | Disposition (change in control) | 29,610 | $261.25 | $7,735,610.00 | (100%) 29.61K to 0 | |
| 28-May-15 6:51 PM View: | Smith David Duane Director | Pharmacyclics Inc. (PCYC) | 26-May-15 | Disposition (change in control) | 3,000 | $261.25 | $783,750.00 | (100%) 3.0K to 0 | |
| 28-May-15 6:37 PM View: | Tomasello Shawn Chief Commercial Officer | Pharmacyclics Inc. (PCYC) | 26-May-15 | Disposition (change in control) | 202 | $261.25 | $52,772.50 | (100%) 0.2K to 0 | |
| 28-May-15 6:33 PM View: | Zanganeh Maky Chief Operating Officer | Pharmacyclics Inc. (PCYC) | 26-May-15 | Disposition (change in control) | 351,293 | $261.25 | $91,775,296.00 | (82%) 428.28K to 76.99K | |
| 28-May-15 6:35 PM View: | Soni Manmeet Singh Chief Financial Officer | Pharmacyclics Inc. (PCYC) | 26-May-15 | Disposition | 54,000 | $261.25 | $14,107,500.00 | (98%) 54.87K to 0.87K | |
| 28-May-15 7:01 PM View: | Booth Robert F. Director | Pharmacyclics Inc. (PCYC) | 26-May-15 | Disposition | 10,000 | $261.25 | $2,612,500.00 | (100%) 10.0K to 0 | |
| 28-May-15 6:35 PM View: | Soni Manmeet Singh Chief Financial Officer | Pharmacyclics Inc. (PCYC) | 26-May-15 | Disposition (change in control) | 873 | $261.25 | $228,071.00 | (100%) 0.87K to 0 | |
| 28-May-15 6:30 PM View: | Duggan Robert W Chairman and CEO Director 10% Owner | Pharmacyclics Inc. (PCYC) | 26-May-15 | Disposition (change in control) | 13,225,500 | $261.25 | $3,455,170,048.00 | (49%) 26.82M to 13.59M | |
| 28-May-15 7:25 PM View: | Halvorson Eric H Director | Pharmacyclics Inc. (PCYC) | 26-May-15 | Disposition (change in control) | 1,000 | $261.25 | $261,250.00 | (100%) 1.0K to 0 | |
| 28-May-15 6:37 PM View: | Tomasello Shawn Chief Commercial Officer | Pharmacyclics Inc. (PCYC) | 26-May-15 | Disposition | 50,000 | $261.25 | $13,062,500.00 | (87%) 57.5K to 7.5K | |
| 13-Apr-15 8:38 PM View: | Tan Heow Chief Quality&Tech Operations | Pharmacyclics Inc. (PCYC) | 13-Apr-15 | Option Exercise | 3,696 | $27.05 | $99,976.80 | 48% 7.77K to 11.46K | |
| 28-May-15 6:30 PM View: | Duggan Robert W Chairman and CEO Director 10% Owner | Pharmacyclics Inc. (PCYC) | 18-Mar-15 | Gift | 4,785 | -- | -- | (< 1%) 26.79M to 26.79M | |
| 17-Mar-15 8:05 PM View: | Tan Heow Chief Quality&Tech Operations | Pharmacyclics Inc. (PCYC) | 17-Mar-15 | Option Exercise | 3,696 | $27.05 | $99,976.80 | 91% 4.07K to 7.77K | |
| 28-May-15 6:30 PM View: | Duggan Robert W Chairman and CEO Director 10% Owner | Pharmacyclics Inc. (PCYC) | 17-Mar-15 | Gift | 152,635 | -- | -- | (< 1%) 26.95M to 26.79M | |
| 13-Mar-15 6:25 PM View: | Soni Manmeet Singh Chief Financial Officer | Pharmacyclics Inc. (PCYC) | 13-Mar-15 | Market Sale | 3,416 | $254.90 | $870,756.00 | (6%) 58.03K to 54.61K | (2%) |
| 13-Mar-15 5:54 PM View: | Zanganeh Maky Chief Operating Officer | Pharmacyclics Inc. (PCYC) | 12-Mar-15 | Option Exercise | 92,500 | $0.75 | $69,375.00 | 23% 398.74K to 491.24K | |
| 12-Mar-15 7:24 PM View: | Tan Heow Chief Quality&Tech Operations | Pharmacyclics Inc. (PCYC) | 12-Mar-15 | Market Option Sale | 1,000 | $254.51 | $254,506.00 | (20%) 5.07K to 4.07K | (3%) |
| 13-Mar-15 5:54 PM View: | Zanganeh Maky Chief Operating Officer | Pharmacyclics Inc. (PCYC) | 12-Mar-15 | Option Exercise | 48,219 | $2.30 | $110,904.00 | (10%) 491.24K to 443.02K | |
| 12-Mar-15 7:24 PM View: | Tan Heow Chief Quality&Tech Operations | Pharmacyclics Inc. (PCYC) | 12-Mar-15 | Option Exercise | 1,000 | $27.05 | $27,050.00 | 25% 4.07K to 5.07K | |
| 13-Mar-15 6:25 PM View: | Soni Manmeet Singh Chief Financial Officer | Pharmacyclics Inc. (PCYC) | 11-Mar-15 | Market Option Sale | 24,098 | $254.15 | $6,124,510.00 | (29%) 82.13K to 58.03K | (3%) |
| 13-Mar-15 5:54 PM View: | Zanganeh Maky Chief Operating Officer | Pharmacyclics Inc. (PCYC) | 11-Mar-15 | Option Exercise | 30,000 | $7.19 | $215,700.00 | 10% 302.3K to 332.3K | |
| 13-Mar-15 5:54 PM View: | Zanganeh Maky Chief Operating Officer | Pharmacyclics Inc. (PCYC) | 11-Mar-15 | Market Option Sale | 30,000 | $254.12 | $7,623,440.00 | (9%) 332.3K to 302.3K | (3%) |
| 13-Mar-15 6:25 PM View: | Soni Manmeet Singh Chief Financial Officer | Pharmacyclics Inc. (PCYC) | 11-Mar-15 | Option Exercise | 24,098 | $75.06 | $1,808,850.00 | 42% 58.03K to 82.13K | |
| 04-Mar-15 7:55 PM View: | Soni Manmeet Singh Chief Financial Officer | Pharmacyclics Inc. (PCYC) | 03-Mar-15 | Payment of Exercise | 2,584 | $216.76 | $560,121.00 | (4%) 60.61K to 58.03K | (21%) |
| 23-Jan-15 6:14 PM View: | Booth Robert F. Director | Pharmacyclics Inc. (PCYC) | 22-Jan-15 | Grant | 10,000 | -- | -- | 100% 0 to 10.0K | |
| 21-Jan-15 5:09 PM View: | Soni Manmeet Singh Chief Financial Officer | Pharmacyclics Inc. (PCYC) | 16-Jan-15 | Grant | 22,000 | -- | -- | 57% 38.61K to 60.61K | |
| 21-Jan-15 5:12 PM View: | Zanganeh Maky Chief Operating Officer | Pharmacyclics Inc. (PCYC) | 16-Jan-15 | Grant | 15,000 | -- | -- | 5% 287.3K to 302.3K | |
| 13-Feb-15 6:18 PM View: | Duggan Robert W Chairman and CEO Director 10% Owner | Pharmacyclics Inc. (PCYC) | 05-Dec-14 | Disposition (other) | 200,740 | -- | -- | (< 1%) 27.31M to 27.11M | |
| 13-Feb-15 6:18 PM View: | Duggan Robert W Chairman and CEO Director 10% Owner | Pharmacyclics Inc. (PCYC) | 04-Dec-14 | Gift | 617 | -- | -- | (< 1%) 27.31M to 27.31M | |
| 13-Feb-15 6:18 PM View: | Duggan Robert W Chairman and CEO Director 10% Owner | Pharmacyclics Inc. (PCYC) | 03-Dec-14 | Gift | 2,000 | -- | -- | (< 1%) 27.31M to 27.31M | |
| 13-Feb-15 6:18 PM View: | Duggan Robert W Chairman and CEO Director 10% Owner | Pharmacyclics Inc. (PCYC) | 19-Nov-14 | Gift | 35,517 | -- | -- | (< 1%) 27.35M to 27.31M | |
| 20-Nov-14 7:17 PM View: | Tomasello Shawn Chief Commercial Officer | Pharmacyclics Inc. (PCYC) | 19-Nov-14 | Disposition | 5,390 | $138.37 | $745,801.00 | (9%) 62.5K to 57.11K | (89%) |
| 13-Feb-15 6:18 PM View: | Duggan Robert W Chairman and CEO Director 10% Owner | Pharmacyclics Inc. (PCYC) | 18-Nov-14 | Gift | 2,000 | -- | -- | (< 1%) 27.35M to 27.35M | |
| 17-Nov-14 4:19 PM View: | Soni Manmeet Singh Chief Financial Officer | Pharmacyclics Inc. (PCYC) | 13-Nov-14 | Option Exercise | 1,000 | $61.60 | $61,600.00 | 3% 38.61K to 39.61K | |
| 17-Nov-14 4:30 PM View: | Fardis Maria Chief of Oncology Ops & Allian | Pharmacyclics Inc. (PCYC) | 13-Nov-14 | Option Exercise | 3,000 | $6.84 | $20,520.00 | 94% 3.19K to 6.19K | |
| 17-Nov-14 4:30 PM View: | Fardis Maria Chief of Oncology Ops & Allian | Pharmacyclics Inc. (PCYC) | 13-Nov-14 | Market Option Sale | 3,000 | $141.30 | $423,902.00 | (48%) 6.19K to 3.19K | (85%) |
| 13-Feb-15 6:18 PM View: | Duggan Robert W Chairman and CEO Director 10% Owner | Pharmacyclics Inc. (PCYC) | 13-Nov-14 | Gift | 1,504 | -- | -- | (< 1%) 27.35M to 27.35M | |
| 17-Nov-14 4:19 PM View: | Soni Manmeet Singh Chief Financial Officer | Pharmacyclics Inc. (PCYC) | 13-Nov-14 | Market Option Sale | 1,000 | $141.44 | $141,442.00 | (3%) 39.61K to 38.61K | (85%) |
| 12-Nov-14 6:07 PM View: | Zanganeh Maky Chief Operating Officer | Pharmacyclics Inc. (PCYC) | 12-Nov-14 | Market Option Sale | 5,931 | $137.96 | $818,216.00 | (2%) 293.23K to 287.3K | (89%) |
| 12-Nov-14 6:07 PM View: | Zanganeh Maky Chief Operating Officer | Pharmacyclics Inc. (PCYC) | 12-Nov-14 | Option Exercise | 5,931 | $7.19 | $42,643.90 | 2% 287.3K to 293.23K | |
| 10-Nov-14 6:30 PM View: | Love Richard B General Counsel | Pharmacyclics Inc. (PCYC) | 10-Nov-14 | Option Exercise | 1,500 | $32.38 | $48,570.00 | 732% 0.2K to 1.71K | |
| 12-Nov-14 6:07 PM View: | Zanganeh Maky Chief Operating Officer | Pharmacyclics Inc. (PCYC) | 10-Nov-14 | Option Exercise | 23,000 | $2.30 | $52,900.00 | 8% 287.3K to 310.3K | |
| 12-Nov-14 6:07 PM View: | Zanganeh Maky Chief Operating Officer | Pharmacyclics Inc. (PCYC) | 10-Nov-14 | Market Option Sale | 23,000 | $133.83 | $3,078,030.00 | (7%) 310.3K to 287.3K | (95%) |
| 10-Nov-14 6:30 PM View: | Love Richard B General Counsel | Pharmacyclics Inc. (PCYC) | 10-Nov-14 | Market Option Sale | 1,500 | $133.87 | $200,805.00 | (88%) 1.71K to 0.2K | (95%) |
| 10-Nov-14 6:28 PM View: | Fardis Maria Chief of Oncology Ops & Allian | Pharmacyclics Inc. (PCYC) | 07-Nov-14 | Option Exercise | 5,000 | $6.84 | $34,200.00 | 157% 3.19K to 8.19K |
